Found: 112
Select item for more details and to access through your institution.
VFMSS findings in elderly dysphagic patients: our experience.
- Published in:
- BMC Surgery, 2013, v. 13, n. Suppl 2, p. 1, doi. 10.1186/1471-2482-13-S2-S54
- By:
- Publication type:
- Article
VFMSS findings in elderly dysphagic patients: our experience.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 10, p. 1710, doi. 10.1093/ndt/gfae075
- By:
- Publication type:
- Article
Iron biology.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1404, doi. 10.1093/ndt/gfae095
- By:
- Publication type:
- Article
Cardio-renoprotective effects of SGLT2 inhibitors—the role of anaemia correction.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 6, p. 904, doi. 10.1093/ndt/gfae019
- By:
- Publication type:
- Article
COVID-19 and cardiovascular disease in patients with chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 2, p. 177, doi. 10.1093/ndt/gfad170
- By:
- Publication type:
- Article
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 11, p. 2444, doi. 10.1093/ndt/gfad112
- By:
- Publication type:
- Article
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 1, p. 10, doi. 10.1093/ndt/gfab167
- By:
- Publication type:
- Article
Dialysis dose and mortality: where is the limit?
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 12, p. 2170, doi. 10.1093/ndt/gfab265
- By:
- Publication type:
- Article
A new paradigm in treating patients with chronic kidney disease and anaemia after a journey lasting more than 35 years.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 9, p. 1559, doi. 10.1093/ndt/gfab177
- By:
- Publication type:
- Article
Are all erythropoiesis-stimulating agents created equal?
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 8, p. 1369, doi. 10.1093/ndt/gfaa034
- By:
- Publication type:
- Article
The evolution of the therapeutic approach to membranous nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 5, p. 768, doi. 10.1093/ndt/gfaa014
- By:
- Publication type:
- Article
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 2, p. 267, doi. 10.1093/ndt/gfaa088
- By:
- Publication type:
- Article
Are prolyl-hydroxylase inhibitors potential alternative treatments for anaemia in patients with chronic kidney disease?
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 6, p. 926, doi. 10.1093/ndt/gfz031
- By:
- Publication type:
- Article
New agents to reduce cholesterol levels: implications for nephrologists.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 2, p. 213, doi. 10.1093/ndt/gfz013
- By:
- Publication type:
- Article
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
- Published in:
- Nephrology Dialysis Transplantation, 2020, v. 35, n. 1, p. 138, doi. 10.1093/ndt/gfy217
- By:
- Publication type:
- Article
Will the results of the Proactive IV Iron Therapy in Haemodialysis Patients trial impact the anaemia guidelines?
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 12, p. 1991, doi. 10.1093/ndt/gfz052
- By:
- Publication type:
- Article
Haemodialysis or haemodiafiltration: that is the question.
- Published in:
- Nephrology Dialysis Transplantation, 2018, v. 33, n. 11, p. 1896, doi. 10.1093/ndt/gfy035
- By:
- Publication type:
- Article
Ferric Carboxymatose in Non-Hemodialysis CKD Patients: A Longitudinal Cohort Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 6, p. 1322, doi. 10.3390/jcm10061322
- By:
- Publication type:
- Article
ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 839, doi. 10.3390/jcm10040839
- By:
- Publication type:
- Article
Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 793, doi. 10.3390/jcm10040793
- By:
- Publication type:
- Article
Nutritional Issues with Incremental Dialysis: The Role of Low-Protein Diets.
- Published in:
- 2017
- By:
- Publication type:
- journal article
What We Know About Oxidative Stress in Patients with Chronic Kidney Disease on Dialysis-Clinical Effects, Potential Treatment, and Prevention.
- Published in:
- Seminars in Dialysis, 2011, v. 24, n. 1, p. 56, doi. 10.1111/j.1525-139X.2010.00819.x
- By:
- Publication type:
- Article
How Can Prognosis for Diabetic ESRD Be Improved?
- Published in:
- Seminars in Dialysis, 2010, v. 23, n. 2, p. 214, doi. 10.1111/j.1525-139X.2010.00709.x
- By:
- Publication type:
- Article
Editorial: IgA nephropathy: a nephrologist's challenge in 2023.
- Published in:
- Frontiers in Nephrology, 2024, p. 1, doi. 10.3389/fneph.2024.1477350
- By:
- Publication type:
- Article
Drugs in Development to Treat IgA Nephropathy.
- Published in:
- Drugs, 2024, v. 84, n. 5, p. 503, doi. 10.1007/s40265-024-02036-1
- By:
- Publication type:
- Article
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors.
- Published in:
- Drugs, 2022, v. 82, n. 16, p. 1565, doi. 10.1007/s40265-022-01783-3
- By:
- Publication type:
- Article
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1491, doi. 10.1007/s40265-021-01573-3
- By:
- Publication type:
- Article
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies.
- Published in:
- Drugs, 2021, v. 81, n. 13, p. 1467, doi. 10.1007/s40265-021-01555-5
- By:
- Publication type:
- Article
α- and β-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.
- Published in:
- Journal of Molecular Medicine, 2010, v. 88, n. 2, p. 203, doi. 10.1007/s00109-009-0549-x
- By:
- Publication type:
- Article
Method Comparison of Erythrocyte Sedimentation Rate Automated Systems, the VES-MATIC 5 (DIESSE) and Test 1 (ALIFAX), with the Reference Method in Routine Practice.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 847, doi. 10.3390/jcm13030847
- By:
- Publication type:
- Article
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7260, doi. 10.3390/jcm12237260
- By:
- Publication type:
- Article
A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 12, p. 4110, doi. 10.3390/jcm12124110
- By:
- Publication type:
- Article
Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5847, doi. 10.3390/jcm10245847
- By:
- Publication type:
- Article
Safety and Efficacy of Eculizumab Therapy in Multiple Sclerosis: A Case Series.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 10, p. 1341, doi. 10.3390/brainsci11101341
- By:
- Publication type:
- Article
Postdialysis Hypertension: Associated Factors, Patient Profiles, and Cardiovascular Mortality.
- Published in:
- American Journal of Hypertension, 2016, v. 29, n. 6, p. 684, doi. 10.1093/ajh/hpv162
- By:
- Publication type:
- Article
Blood Pressure and Cardiovascular Mortality in Dialysis Patients With Left Ventricular Systolic Dysfunction.
- Published in:
- American Journal of Hypertension, 2014, v. 27, n. 3, p. 401
- By:
- Publication type:
- Article
RALLENTARE LA PROGRESSIONE DEL DANNO RENALE OGGI. LA MALATTIA RENALE CRONICA: UN RILEVANTE PROBLEMA PERSONALE, FAMILIARE E SOCIALE.
- Published in:
- Giornale Italiano di Nefrologia, 2012, v. 29, p. S54
- By:
- Publication type:
- Article
RISPOSTA EMATOPOIETICA INIZIALE ALLA TERAPIA CON ESA: FATTORE PROGNOSTICO IMPORTANTE?
- Published in:
- Giornale Italiano di Nefrologia, 2011, v. 28, n. 3, p. 251
- By:
- Publication type:
- Article
LUCI ED OMBRE DEL BLOCCO SINGOLO O DOPPIO DEL RAAS.
- Published in:
- Giornale Italiano di Nefrologia, 2010, v. 27, n. 5, p. 477
- By:
- Publication type:
- Article
I RISULTATI DELLO STUDIO TREAT: INSEGNAMENTI E LIMITI.
- Published in:
- Giornale Italiano di Nefrologia, 2010, v. 27, n. 1, p. 3
- By:
- Publication type:
- Article
I BIOSIMILARI DELL'ERITROPOIETINA: SI APRE UN NUOVO CAPITOLO?
- Published in:
- Giornale Italiano di Nefrologia, 2008, v. 25, n. 4, p. 385
- By:
- Publication type:
- Article
International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.
- Published in:
- International Journal of Health Care Finance & Economics, 2007, v. 7, n. 2/3, p. 201, doi. 10.1007/s10754-007-9016-9
- By:
- Publication type:
- Article
Pure Red Cell Aplasia Secondary to Treatment with Erythropoietin.
- Published in:
- Artificial Organs, 2003, v. 27, n. 9, p. 755, doi. 10.1046/j.1525-1594.2003.00991.x
- By:
- Publication type:
- Article
Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 9, p. 1, doi. 10.1093/ckj/sfae237
- By:
- Publication type:
- Article
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 3, p. 1, doi. 10.1093/ckj/sfae044
- By:
- Publication type:
- Article
Systemic and targeted steroids for the treatment of IgA nephropathy.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, p. ii40, doi. 10.1093/ckj/sfad224
- By:
- Publication type:
- Article
The anaemia treatment journey of CKD patients: from epoetins to hypoxia-inducible factor-prolyl hydroxylase inhibitors.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 10, p. 1563, doi. 10.1093/ckj/sfad105
- By:
- Publication type:
- Article
Intravenous iron therapy and the cardiovascular system: risks and benefits.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 4, p. 1067, doi. 10.1093/ckj/sfaa212
- By:
- Publication type:
- Article